Oral Glucose Tolerance Test Explained

The oral glucose tolerance test (OGTT) is the most sensitive standard diagnostic test for detecting impaired glucose metabolism — more sensitive than fasting glucose alone and more informative than a single random measurement. It is the gold standard for diagnosing gestational diabetes and is widely used to identify impaired glucose tolerance (prediabetes) and diabetes in adults when other screening tests yield uncertain or borderline results. Understanding exactly what the test measures, how it is performed, what the results mean, and when it is and is not the most appropriate test to use provides important context for anyone who has been referred for this testing or who wants to understand their diabetes screening comprehensively. For the broader framework of blood sugar testing options, see our guide on what is normal blood sugar, and for context on the A1C test that is often used alongside or instead of the OGTT, see our guide on the A1C test.

What the Oral Glucose Tolerance Test Measures

The OGTT measures the body’s ability to clear a standardized glucose load from the bloodstream over a defined period. Unlike a fasting glucose test — which captures only the overnight basal glucose level — or an A1C test — which reflects an average over the past two to three months — the OGTT specifically tests dynamic glucose metabolism: how rapidly and completely the body responds to a sudden, large influx of glucose. This dynamic quality is what makes the OGTT uniquely sensitive for detecting early-stage glucose regulation problems.

The physiological process the test is examining is the post-meal insulin response. When glucose is absorbed into the bloodstream after a meal or glucose drink, the pancreatic beta cells must detect the rising glucose and release sufficient insulin within the right timeframe to drive glucose uptake into muscle, liver, and fat cells — clearing the glucose back to baseline within approximately two hours. In a metabolically healthy person with good insulin sensitivity and intact beta cell function, this clearance happens efficiently and two-hour glucose returns to below 140 mg/dL. In a person with early insulin resistance, the glucose peak is higher and clearance is slower — two-hour glucose may be in the 140–199 mg/dL range (impaired glucose tolerance, or prediabetes). In diabetes, two-hour glucose is 200 mg/dL or above — indicating that the insulin response is insufficient to clear the glucose load within the two-hour window. Understanding how the body controls blood sugar provides the physiological foundation for interpreting why these thresholds are clinically meaningful. The concept of insulin resistance is particularly relevant because it is the early-stage impairment that the OGTT is most sensitive for detecting before it progresses to full diabetes.

How the Test Is Performed

The standard adult OGTT procedure is straightforward but requires specific preparation and testing conditions for the result to be valid and comparable to the diagnostic reference ranges.

Preparation (2–3 days before): The person should maintain a normal diet for at least three days before the test — specifically consuming at least 150 grams of carbohydrates daily. Severely restricting carbohydrates before the test can artificially impair the insulin response and produce falsely elevated OGTT results. The test should not be performed during acute illness, significant physical or psychological stress, or while taking medications known to affect glucose metabolism if these are avoidable — beta-blockers, corticosteroids, and certain diuretics can affect results. Healthcare providers ordering the test should review current medications and determine whether any need to be temporarily held.

Fasting period: An overnight fast of eight to ten hours is required before the test. Water is permitted during the fast; other beverages, food, caffeine, and smoking should be avoided from the start of the fast until the test is complete.

Baseline blood draw: On the morning of the test, a fasting blood glucose sample is drawn. This confirms the fasting state and establishes a baseline. If the fasting glucose is already above 200 mg/dL, the OGTT may be unnecessary (the glucose level itself may be sufficient for a diabetes diagnosis), and the healthcare provider will determine whether to proceed.

Glucose solution consumption: The patient drinks a standardized glucose solution containing 75 grams of glucose dissolved in approximately 250–300 mL of water — often consumed within five minutes. A standard flavored formulation is used clinically. The glucose load must be standardized at exactly 75 grams for the results to be interpreted against the established diagnostic thresholds; non-standard glucose loads produce non-comparable results. (A different dose — 50 or 100 grams — is used for gestational diabetes screening, as detailed below.)

Two-hour blood draw: The definitive diagnostic sample is drawn exactly two hours after the glucose solution was consumed. Physical activity, eating, and smoking are avoided during the two-hour waiting period, as these can affect glucose levels. Some protocols also draw a one-hour sample, which provides additional information about the glucose peak and is required in some gestational diabetes protocols.

Interpreting OGTT Results

The primary diagnostic decision point for the OGTT is the two-hour plasma glucose value. The three-way classification — normal, impaired glucose tolerance, and diabetes — is based on population-level evidence about where complication risk rises and where intervention benefit has been demonstrated.

Normal glucose tolerance (two-hour glucose below 140 mg/dL): The insulin response was sufficient to clear the 75g glucose load within two hours. This result is reassuring but does not completely rule out metabolic risk — some people with normal OGTT results may have high glucose variability at post-meal peaks before the two-hour mark, or may be in the early stages of declining insulin sensitivity that has not yet manifested as impaired two-hour clearance. For people with significant diabetes risk factors (family history, overweight/obesity, sedentary lifestyle, cardiovascular disease), even a normal result is best understood as a baseline to be repeated periodically rather than a definitive clearance of long-term risk. For the full range of diabetes risk factors that determine how frequently re-screening is appropriate, see our guide on diabetes risk factors every adult should know.

Impaired glucose tolerance (two-hour glucose 140–199 mg/dL): The body cleared the glucose load more slowly than normal — indicating that either insulin secretion, insulin sensitivity, or both are suboptimal. This result, often called prediabetes, represents a high-risk state but not yet diabetes. Landmark clinical trials — the Diabetes Prevention Program in the United States and equivalent studies in Europe and Asia — have established that impaired glucose tolerance identified by OGTT is reversible through lifestyle intervention: a reduction in body weight of 5–7% combined with 150 minutes of moderate physical activity per week reduces progression from impaired glucose tolerance to diabetes by approximately 58% over three years. This is why detecting impaired glucose tolerance through OGTT matters so much — it identifies people in the window when intervention most effectively prevents disease. For a comprehensive understanding of what prediabetes means and what to do about it, see our guide on what prediabetes is.

Diabetes (two-hour glucose 200 mg/dL or above): Confirmed diabetes diagnosis. A single OGTT result of 200+ mg/dL at two hours is generally sufficient for diabetes diagnosis if accompanied by classic symptoms (excessive thirst, frequent urination, unexplained weight loss). In the absence of classic symptoms, a second confirmatory test is recommended — either a repeat OGTT, a fasting glucose above 126 mg/dL, an A1C of 6.5% or above, or a random glucose above 200 mg/dL with symptoms. This confirmation requirement exists because test result errors, acute illness, and temporary physiological states can occasionally produce elevated glucose readings that do not reflect chronic diabetes. For the full diagnostic criteria for diabetes and an explanation of what the diagnosis means for long-term health, see our guide on what diabetes is.

OGTT for Gestational Diabetes Screening

The most common clinical application of the OGTT in modern practice is gestational diabetes screening — testing pregnant women for glucose metabolism impairment that appears specifically during pregnancy. Gestational diabetes affects an estimated 6–9% of pregnancies and carries significant risks for both mother and baby if undetected and unmanaged, making systematic screening a standard part of prenatal care.

Two different screening protocols exist for gestational diabetes, and the choice between them varies by country and clinical guidelines. The two-step approach (used primarily in the United States) begins with a 50-gram, one-hour glucose challenge test (GCT) that does not require fasting — if the one-hour glucose is above the screening threshold (typically 130 or 140 mg/dL depending on the protocol), a diagnostic 100-gram, three-hour OGTT is performed. The one-step approach (favored internationally and increasingly in the United States) performs a single 75-gram, two-hour OGTT with fasting at 24–28 weeks of pregnancy, classifying gestational diabetes if fasting glucose is 92+ mg/dL, one-hour glucose is 180+ mg/dL, or two-hour glucose is 153+ mg/dL (any one value is sufficient for the diagnosis under the IADPSG criteria). The gestational diabetes glucose thresholds are considerably more stringent than the standard adult diabetes thresholds because the developing fetus is highly sensitive to maternal glucose even at levels below the standard diabetes diagnostic cutoffs. Elevated maternal glucose drives fetal overgrowth (macrosomia), increases the risk of difficult delivery, and can cause neonatal hypoglycemia after birth — risks that begin to accumulate at glucose levels that would be considered merely borderline in a non-pregnant adult.

A separate consideration is that gestational diabetes, while typically resolving after delivery, is a strong predictor of future Type 2 diabetes: women who had gestational diabetes have approximately a 50% lifetime risk of developing Type 2 diabetes, with the highest-risk period being the five to ten years after the index pregnancy. For this reason, postpartum glucose testing — a 75-gram OGTT at six to twelve weeks after delivery — is recommended for all women who had gestational diabetes, and annual glucose screening (fasting glucose or A1C) is recommended thereafter. The diabetes risk factors guide covers gestational diabetes history as a significant risk factor for future diabetes in the context of comprehensive diabetes risk assessment.

When the OGTT Is Used Instead of Other Tests

The OGTT is not the routine first-line screening test for diabetes in most clinical settings — for most adults, initial screening is done with fasting glucose or A1C because these are more convenient (no two-hour waiting period, fasting glucose and A1C do not require the glucose drink). The OGTT is used in specific clinical contexts where it provides information that fasting glucose and A1C cannot.

Discordant fasting glucose and A1C results: When fasting glucose is in the normal range but A1C is in the prediabetes or diabetes range (or vice versa), the OGTT can resolve the discrepancy by directly measuring glucose clearance capacity. Some people have normal fasting glucose but markedly impaired post-meal clearance — they look metabolically normal in the fasting state but have significant post-meal glucose elevation. The OGTT detects this pattern; fasting glucose alone misses it. Our guide on A1C vs blood glucose explains the diagnostic significance of these discordant patterns and when additional testing is needed to resolve them.

Conditions that invalidate A1C: Hemolytic anemia, iron deficiency anemia, sickle cell disease, and other hemoglobin variants can artifactually raise or lower A1C, making it unreliable as a diagnostic tool in affected individuals. In these cases, glucose-based testing — fasting glucose and/or OGTT — is necessary. The two-step process of first checking whether A1C is likely to be reliable in a given patient before relying on it for diagnosis is an important part of equitable diabetes screening across diverse populations.

Suspected diabetes despite normal fasting glucose: Post-meal glucose impairment frequently precedes fasting glucose elevation in the natural history of insulin resistance. A person can have entirely normal fasting glucose for years while their post-meal glucose progressively rises — and the OGTT will detect this post-meal impairment that the fasting glucose test misses. Individuals with multiple diabetes risk factors (obesity, family history, sedentary lifestyle, history of gestational diabetes, polycystic ovary syndrome) who have normal fasting glucose but are strongly suspected of having glucose metabolism impairment may benefit from OGTT to detect early post-meal dysglycemia. Understanding the early signs of high blood sugar — symptoms that may appear even before diagnostic thresholds are formally crossed — can help guide the decision about whether additional sensitivity testing is warranted.

Research and clinical trials: In clinical research settings, the OGTT remains the reference standard for diagnosing impaired glucose tolerance because its results correlate most directly with the evidence base for diabetes prevention interventions. The major diabetes prevention trials that established the efficacy of lifestyle intervention enrolled participants based on OGTT-confirmed impaired glucose tolerance — making the OGTT the appropriate diagnostic tool for identifying candidates for formal diabetes prevention programs. Looking at the random blood sugar test alongside the OGTT provides a complete picture of all available glucose testing options and the distinct clinical role each plays. For context on how the blood sugar monitoring framework fits together across all available tests, the full picture is covered in our guide on blood sugar chart for adults, which brings together the diagnostic thresholds from all major testing approaches in a single reference. And for anyone whose OGTT results come back in the impaired glucose tolerance range, the immediate next steps — lifestyle modifications with the greatest evidence for preventing progression — are covered comprehensively in our guides on what prediabetes is and the upstream risk factors most important to address in diabetes risk factors every adult should know.

Limitations and Factors That Can Affect OGTT Results

While the OGTT is the most sensitive standard test for glucose metabolism impairment, it has several known sources of variability that are important to understand when interpreting results — particularly borderline results in the impaired glucose tolerance range.

Within-person variability: Repeated OGTT testing in the same person can yield results that differ by 10–20 mg/dL at the two-hour measurement, even under identical preparation conditions. This variability arises from natural day-to-day biological fluctuation in insulin secretion, stress hormone levels, physical activity the day before testing, and other factors. This is one reason that a result in the 140–160 mg/dL range — at the lower end of the impaired glucose tolerance category — is interpreted cautiously, and why repeat testing or use of additional diagnostic methods (A1C, fasting glucose) is often recommended before making a definitive prediabetes diagnosis based on a single borderline OGTT result. A result consistently above 180 mg/dL at two hours across repeated testing, however, is more definitively in the impaired glucose tolerance range.

Preparation compliance: The OGTT result depends critically on the preparatory dietary pattern in the days before the test. Carbohydrate restriction in the days before testing — whether deliberate (low-carbohydrate diet) or inadvertent (illness reducing appetite) — can impair the insulin response to the glucose load and produce artificially elevated two-hour results. Healthcare providers ordering the OGTT should explicitly instruct patients to maintain their usual diet with at least 150 grams of carbohydrates daily for the three days before the test, and the interpreting clinician should ask about any recent dietary changes or illness before interpreting a borderline or elevated result.

Activity during the test: Physical activity after consuming the glucose solution and before the two-hour blood draw can significantly lower the two-hour glucose — exercise increases glucose uptake into muscles independently of insulin, which can artificially improve the apparent glucose clearance. Patients should remain seated or resting during the two-hour waiting period. Even a short walk during the waiting period can reduce the two-hour glucose by 10–20 mg/dL in some individuals, potentially moving a result from the diabetes category to the impaired glucose tolerance range or from impaired glucose tolerance to normal.

Medications: Many common medications affect insulin sensitivity or glucose metabolism and can confound OGTT results. Corticosteroids (prednisone, dexamethasone) raise blood glucose and can produce abnormal OGTT results in metabolically normal individuals; beta-blockers can impair insulin secretion; thiazide diuretics can raise fasting and post-load glucose. When interpreting an OGTT in a person taking these medications, the result must be understood in the context of the expected medication effect. Where clinically feasible and safe, some protocols hold offending medications on the day of testing, though this is not always practical or appropriate.

Stress and illness: Acute illness, significant psychological stress, surgery, and trauma all trigger counter-regulatory hormone responses (cortisol, glucagon, catecholamines) that raise blood glucose and impair insulin action. OGTT performed during or shortly after acute illness can yield falsely elevated results. Guidelines generally recommend waiting at least two weeks after resolution of any significant acute illness before performing an OGTT intended for diabetes diagnosis, to ensure the result reflects chronic metabolic status rather than an acute stress response.

After the Test: What to Expect and Next Steps

After the two-hour blood draw, the test is complete and the patient can eat, resume normal activity, and take any held medications. Results are typically available within one to three business days through the ordering laboratory and healthcare provider. In many healthcare systems, results can also be accessed through patient portals.

When results come back, the appropriate next step depends on which category the result falls into. For a normal result (two-hour glucose below 140 mg/dL), the next clinical decision is how frequently to re-screen — this depends on risk factor burden, as discussed above. For people with multiple risk factors, re-screening every one to three years is typical; for people with no significant risk factors, re-screening at routine care intervals (every three to five years) may be appropriate. For anyone looking to understand the full range of monitoring options beyond the OGTT itself, our guide on home blood sugar monitoring covers how to use a glucose meter between clinical visits to track glucose patterns, and our guide on how often blood sugar should be checked provides a framework for determining the appropriate testing frequency based on individual clinical circumstances.

For an impaired glucose tolerance result (two-hour glucose 140–199 mg/dL), the clinical conversation should focus on the evidence-based lifestyle interventions that most effectively prevent progression to diabetes: reduction in dietary refined carbohydrate and saturated fat intake, increased physical activity to at least 150 minutes per week of moderate-intensity exercise, and — for those with overweight or obesity — a weight loss target of 5–7% of body weight. These changes, demonstrated to reduce diabetes progression by 58% in the Diabetes Prevention Program, should ideally begin promptly rather than waiting for the next scheduled check-up. In many health systems, formal structured diabetes prevention programs based on the Diabetes Prevention Program curriculum are available and covered by insurance for people with prediabetes confirmed by OGTT or other testing. Metformin, while less effective than lifestyle intervention in the overall trial population, is sometimes offered to people with impaired glucose tolerance who are unable to achieve adequate lifestyle modification, particularly those with other high-risk features (BMI above 35, history of gestational diabetes, multiple risk factors). Our guide on what prediabetes is covers all of these intervention options in detail. For a confirmed diabetes result, the clinical conversation shifts to diabetes management planning — blood glucose monitoring frequency, medication initiation if appropriate, and the long-term monitoring plan for complications. Our guides on what diabetes is and fasting blood sugar explained and post-meal blood sugar explained provide the educational foundation for understanding what the glucose measurements used in ongoing diabetes management are measuring and what they mean, building on the diagnostic information that the OGTT first established.

Sources: American Diabetes Association. Standards of Medical Care in Diabetes — 2024. Diabetes Care. 2024;47(Suppl 1):S20–S42. • Knowler WC, et al. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. N Engl J Med. 2002;346(6):393–403. • IADPSG Consensus Panel. International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy. Diabetes Care. 2010;33(3):676–682.